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Echocardiographic Parameters Predictive of Right Ventricular Function after
MitraClip Implantation
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Background: Impaired right ventricular systolic (RVS) function is of great prognostic
relevance in patients (pts) with mitral valve disease. MitraClip implantation (MCI)
has shown to signiﬁcantly reduce mitral regurgitation (MR) of primary and secondary
etiology. The aim of this subgroup analysis was to assess which left ventricular basic
echocardiographic parameters before the procedure predict the normalization of
initially reduced RVS function
Methods: Out of a total population of n¼323 pts with severe MR who underwent
MCI, we retrospectively included 121 consecutive pts for whom the transthoracic
echocardiography data were available (cases 155-276). Inclusion criterion for
further analysis was an impaired RVS function (TAPSE < 18 mm) before MCI.
MR grade and TAPSE were evaluated at 6 weeks and at 6 months after implan-
tation. Improvement of the RVS function was deﬁned by TAPSE > 18 mm. MR
etiology as well as systolic (LVEF) and diastolic (E/E' Ratio) function of the left
ventricle were tested as predictors of improvement of RVS function (Wilcoxon-
Test).
Results: 39 pts (12 female) with a mean age of 74  11 years were found to
have a reduced TAPSE. 6 weeks after the treatment, TAPSE normalized in 12
(31 %) pts (Group 1), whereas in 27 (69 %) pts it did not (Group 2). Pts in
Group 1 had signiﬁcantly more frequent a MR of primary etiology and
a signiﬁcantly higher LVEF (Table 1) together with a signiﬁcantly lower E/E'
Ratio (Table 1). There was no difference regarding MR reduction between the
two groups. Results at 6 months follow up (31 % of pts) did not differ from 6
weeks data.
Conclusions: Improvement of the right ventricular systolic function after MitraClip
implantation is much more probable in patients with primary mitral regurgitation or
without a severe left ventricular dysfunction.Parameters Group 1 Group 2 Group 3 Group 4 p value
Number of pts 9 (16 %) 4 (7 %) 17 (31 %) 25 (46 %) /
TAPSE pre
MitraClip(mm)
13 [11, 15] 20 [19, 22] 20 [18, 22] 11 [9, 13] < 0.05
TAPSE post
MitraClip (mm)
19 [18, 20] 14.5 [14, 15] 20 [19, 22] 13 [12, 16] < 0.05
D MR by Grade 1 [0.5, 1] 1.5 [1, 2] 1 [0.5, 1.5] 1 [0.5, 1.5] 0.83
DPmean
discharge
(mmHg)
3 [2, 4] 5 [3.5, 5.5] 3 [2, 4.9] 3 [2, 4] 0.33
Parameters Group 1 Group 2 p-value
TAPSE pre
MitraClip [mm]
< 18 < 18 -
TAPSE post
MitraClip [mm]
19 [18, 20] 13 [12, 16] -
Number of pts 12 (31 %) 27 (69 %) -
D MR by Grade 1 [0.5, 1] 1 [0.5, 2] 0.64
LVEF [%] 59 [49, 60] 27 [22, 33] <0.05
E/E' Ratio > 12 0 (0 %) 26 (96 %) <0.05
MR primary
etiology
12 (100 %) 2 (8 %) <0.05
P
O
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Background: Echocardiographic assessments of mitral valve tethering were identiﬁed
as predictors of recurrent functional mitral regurgitation (MR) following surgical
annuloplasty. This report details the implications of these predictors of recurrent
functional MR following percutaneous mitral valve repair with the MitraClip device.
Methods: Eighty-four out of 92 (91%) consecutive patients with functional MR
achieved successful MR reduction (MR  2+ on discharge) following the MitraClip
procedure; 80 patients with follow up MR assessments were reviewed. Pre-procedural
transesophageal echocardiographic measurements of the mitral annulus diameter,
tethering angles, height and area on the mid-esophageal long axis view were collated
(Figure 1).JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrResults: Over a mean follow-up of 26 months, recurrent MR grade  3+ developed
in 14 (17.5%) patients. Baseline distribution of age, sex, left ventricular systolic
function and dimensions were similar between patients with and without MR
recurrence. The tethering area was the only measurement signiﬁcantly associated
with MR recurrence (2.20.9 vs 1.70.7 cm2 in patients without recurrence,
p¼0.042). On multivariate binary logistic stepwise regression, tethering area was an
independent predictor of MR recurrence (odds ratio 2.1, 95% conﬁdence interval:
1.0 to 4.3, p¼0.043).
Conclusions: Echocardiographic assessment of the tethering area could be used to
identify patients at risk of MR recurrence following percutaneous mitral valve repair
for functional MR. These results may guide selection of patients for the MitraClip
procedure and thereby improve long-term efﬁcacy.
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Background: Impaired right ventricular function (RVF) is of great prognostic rele-
vance in patients (pts) with mitral valve disease. MitraClip implantation (MCI) has
shown to signiﬁcantly reduce mitral regurgitation (MR). A possible side effect though
is iatrogenic mitral valve stenosis (IMVS). This preliminary study aims to verify the
impact of IMVS on RVF.
Methods: Out of a total population of 323 pts with severe mitral regurgitation (MR)
who underwent MCI, we retrospectively enrolled those pts for whom right heart
transthoracic echocardiography and sufﬁcient follow-up data were available. The RVF
function was assessed by TAPSE, which was deﬁned as pathological when < 18 mm.
The IMVS was assessed a few days after MCI with cw-doppler based gradient
measurement (ΔP mean discharge).
Results: In 55 pts (22 female; age: 74 +/- 11 years) it was possible to measure:
TAPSE and MR, before and 6 weeks (6W) after MCI and ΔP mean discharge.
Comparing the initial TAPSE to that measured after 6W, we have found 4 Groups of
pts with different patterns of TAPSE development: Group 1, that normalizes its
initially impaired TAPSE; Group 2, that decreases its initially normal TAPSE;
Group 3 with permanently normal TAPSE and Group 4 with permanently patho-
logical TAPSE values. Between the 4 groups there was no signiﬁcant difference in
MR reduction and in ΔP mean discharge (Table 1). Although not statistically
signiﬁcant Group 2 was found to have a higher ΔP mean discharge than all other
groups.
Conclusions: This preliminary study shows that ΔP mean discharge does not predict
right ventricular systolic function after MCI. Although there seems to be a tendency
that pts, with an iatrogenic mitral stenosis, of more than mild severity, worsen their
initially normal TAPSE after the procedure.acts/POSTER/Mitral Valve Disease and Treatment B215
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